Literature DB >> 2721251

Use of mycobacterial smears in the diagnosis of pulmonary tuberculosis in AIDS/ARC patients.

N C Klein1, F P Duncanson, T H Lenox, A Pitta, S C Cohen, G P Wormser.   

Abstract

Pulmonary tuberculosis in AIDS/ARC patients is an increasing problem. To assess the utility of acid-fast smears of pulmonary secretions in this patient population, we evaluated 38 AIDS/ARC patients with culture-positive pulmonary infection. A control group consisted of 57 non-AIDS/ARC patients, who also did not belong to an AIDS risk group, diagnosed during the same period. The number of culture-positive sputum samples evaluated per patient was similar in both groups (3.82 +/- 3.11 AIDS/ARC vs 4.47 +/- 2.83 control group). Significantly fewer AIDS/ARC patients, 45 percent, however, had a positive acid-fast smear compared with the control group, 81 percent (p less than 0.001). The initial sputum smear submitted was positive in only 29 percent of the AIDS/ARC group compared with 61 percent of control subjects (p less than 0.01). Further, greater than or equal to 5 negative smears were found in 60 percent of the evaluable AIDS/ARC patients compared with just 13 percent of control subjects (p less than 0.01). More extensive findings on chest roentgenograms were not associated with a significantly higher yield of smear positivity in the AIDS/ARC group. We conclude that acid-fast smears on sputum specimens are a relatively insensitive test for pulmonary tuberculosis in AIDS/ARC patients.

Entities:  

Mesh:

Year:  1989        PMID: 2721251     DOI: 10.1378/chest.95.6.1190

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  20 in total

Review 1.  AIDS and the lung: update 1992. 2. Recent developments in the management of the pulmonary complications of HIV disease.

Authors:  D M Mitchell; R F Miller
Journal:  Thorax       Date:  1992-05       Impact factor: 9.139

2.  HIV-related incremental yield of bleach sputum concentration and fluorescence technique for the microscopic detection of tuberculosis.

Authors:  S I Eyangoh; G Torrea; M C Tejiokem; Y Kamdem; F F Piam; J Noeske; A Van Deun
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-05-08       Impact factor: 3.267

3.  Diagnostic mycobacteriology: where are we today?

Authors:  G V Doern
Journal:  J Clin Microbiol       Date:  1996-08       Impact factor: 5.948

4.  Incidence and Drug Susceptibility pattern of Mycobacterium tuberculosis in HIV infected Patien.

Authors:  A K Praharaj; A T Kalghatgi; S J Varghese; A Nagendra
Journal:  Med J Armed Forces India       Date:  2011-07-21

Review 5.  Bronchoscopic diagnosis of pneumonia.

Authors:  V S Baselski; R G Wunderink
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

6.  Induction of an AIDS virus-related tuberculosis-like disease in macaques: a model of simian immunodeficiency virus- mycobacterium coinfection.

Authors:  Yun Shen; Dejiang Zhou; Laura Chalifoux; Ling Shen; Meredith Simon; Xuejun Zeng; Xioamin Lai; Yunyuan Li; Prabhat Sehgal; Norman L Letvin; Zheng W Chen
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

Review 7.  Tuberculosis and HIV disease: two decades of a dual epidemic.

Authors:  Muktar H Aliyu; Hamisu M Salihu
Journal:  Wien Klin Wochenschr       Date:  2003-10-31       Impact factor: 1.704

8.  The impact of HIV on the usefulness of sputum smears for the diagnosis of tuberculosis.

Authors:  R Long; M Scalcini; J Manfreda; M Jean-Baptiste; E Hershfield
Journal:  Am J Public Health       Date:  1991-10       Impact factor: 9.308

9.  Trends in tuberculosis/human immunodeficiency virus comorbidity, United States, 1993-2004.

Authors:  Rachel Albalak; Richard J O'Brien; J Steve Kammerer; Sean M O'Brien; Suzanne M Marks; Kenneth G Castro; Marisa Moore
Journal:  Arch Intern Med       Date:  2007-12-10

10.  Treatment outcome of tuberculosis patients at Gondar University Teaching Hospital, Northwest Ethiopia. A five--year retrospective study.

Authors:  Belay Tessema; Abebe Muche; Assegedech Bekele; Dieter Reissig; Frank Emmrich; Ulrich Sack
Journal:  BMC Public Health       Date:  2009-10-04       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.